Investing Ideas
/
Global Pharmaceuticals & Biotech Large Cap High Growth Potential

Global Pharmaceuticals & Biotech Large Cap High Growth Potential

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

1 new

Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.

45 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
ALNY Alnylam Pharmaceuticals	US$278.25	0.4%	64.2%	US$35.6b	US$299.74	PS17.1x	E56.7%	n/a
A196170 ALTEOGEN	₩392,000.00	8.3%	410.4%	₩20.9t	₩565,000.00	PS280.9x	E140.6%	n/a
ITCI Intra-Cellular Therapies	US$127.12	0.09%	77.5%	US$13.5b	US$132.73	PS22x	E52.9%	n/a
SRPT Sarepta Therapeutics	US$112.11	-2.0%	-12.0%	US$11.4b	US$185.16	PE87.9x	E29.9%	n/a
NBIX Neurocrine Biosciences	US$150.51	-1.8%	12.0%	US$15.3b	US$170.63	PE39.5x	E26.8%	n/a
603392 Beijing Wantai Biological Pharmacy Enterprise	CN¥68.01	-0.1%	8.4%	CN¥86.0b	CN¥61.40	PS34.6x	E109.4%	0.5%
ARGX argenx	€638.00	0.5%	75.7%	€38.8b	€632.14	PS21.1x	E41.8%	n/a
LLY Eli Lilly	US$870.37	5.7%	18.3%	US$758.3b	US$976.62	PE74x	E21.6%	0.7%
A068270 Celltrion	₩179,600.00	-0.06%	5.0%	₩38.4t	₩236,564.63	PE203.6x	E73.5%	0.4%
500420 Torrent Pharmaceuticals	₹3,161.35	-5.8%	19.4%	₹1.1t	₹3,639.83	PE57.5x	E23.3%	0.9%
SDZ Sandoz Group	CHF 44.08	1.7%	57.3%	CHF 19.3b	CHF 44.39	PS2.1x	E29.5%	1.0%
AZN AstraZeneca	UK£117.86	4.2%	20.0%	UK£182.8b	UK£139.46	PE35x	E17.1%	1.9%
DIM Sartorius Stedim Biotech	€213.20	-5.4%	-15.1%	€20.7b	€236.43	PE129.2x	E32.3%	0.3%
GALD Galderma Group	CHF 118.54	4.3%	n/a	CHF 28.2b	CHF 104.17	PS7.2x	E36.6%	n/a
EXAS Exact Sciences	US$54.28	-3.1%	-11.0%	US$10.3b	US$72.19	PS3.7x	E59.1%	n/a
ABBV AbbVie	US$192.97	9.9%	10.4%	US$338.8b	US$204.90	PE79.7x	E25.3%	3.4%
UCB UCB	€186.15	-1.7%	106.6%	€35.3b	€196.94	PE147.2x	E28.4%	0.7%
GMAB Genmab	DKK 1,384.50	-1.8%	-27.6%	DKK 87.9b	DKK 2,292.13	PE18.7x	E21.4%	n/a
TECH Bio-Techne	US$75.01	3.1%	10.3%	US$12.0b	US$86.80	PE75.4x	E21.9%	0.4%
BMY Bristol-Myers Squibb	US$57.42	-2.9%	17.9%	US$121.1b	US$61.72	PS2.5x	E47.1%	4.3%
INCY Incyte	US$74.95	1.6%	30.7%	US$14.5b	US$79.76	PE444.5x	E34.2%	n/a
DIVISLAB Divi's Laboratories	₹6,119.70	6.7%	66.1%	₹1.6t	₹5,774.85	PE78.6x	E22.3%	0.5%
LONN Lonza Group	CHF 613.00	3.8%	37.7%	CHF 44.3b	CHF 657.95	PE69.6x	E21.1%	0.7%
ONC BeiGene	US$228.87	0.9%	60.2%	US$24.3b	US$283.39	PS7.6x	E64.6%	n/a

Page 1 of 2